Showing results (1661-1670 of 1,877) with videos related to
Sort By:
Pageof 188
Antimicrobial Agents and Chemotherapy|July 29, 2020
HIV Coinfection Is Associated with Low-Fitness <i>rpoB</i> Variants in Rifampicin-Resistant Mycobacterium tuberculosisChloé Loiseau, Daniela Brites, Miriam Reinhard, et al.Molecular Nutrition & Food Research|October 27, 2023
Dietary Amino Acid Source Elicits Sex-Specific Metabolic Response to Diet-Induced NAFLD in MiceClémence Rives, Céline Marie Pauline Martin, Lauris Evariste, et al.Blood|June 4, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple MyelomaAnaïs Schavgoulidze, Jian Cui, Jessica Encinas, et al.Blood|July 29, 2006
Maintenance therapy with thalidomide improves survival in patients with multiple myelomaMichel Attal, Jean-Luc Harousseau, Serge Leyvraz, et al.Physical Review Letters|July 14, 2023
Dynamics of Nanosecond Laser Pulse Propagation and of Associated Instabilities in a Magnetized Underdense PlasmaW Yao, A Higginson, J-R Marquès, et al.Blood|February 5, 2011
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1S Vincent Rajkumar, Jean-Luc Harousseau, Brian Durie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survivalHervé Avet-Loiseau, Michel Attal, Loic Campion, et al.The Oncologist|May 11, 2012
European perspective on multiple myeloma treatment strategies: update following recent congressesHeinz Ludwig, Hervé Avet-Loiseau, Joan Bladé, et al.Haematologica|December 18, 2012
Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysisAnnalisa Ruggeri, Vanderson Rocha, Emeline Masson, et al.Pageof 188